Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VanItallie, T. B.
Right arrow Articles by Heymsfield, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VanItallie, T. B.
Right arrow Articles by Heymsfield, S. B.
Related Collections
Right arrow Parkinson's disease/Parkinsonism
Right arrow All Clinical trials
Right arrow Clinical trials Observational study (Cohort, Case control)
NEUROLOGY 2005;64:728-730
© 2005 American Academy of Neurology
Brief Communications

Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study

T. B. VanItallie, MD, C. Nonas, RD, A. Di Rocco, MD, K. Boyar, NP, K. Hyams, RD and S. B. Heymsfield, MD

From the Division of Endocrinology, Diabetes, and Nutrition (Drs. VanItallie and Heymsfield, K. Hyams), Department of Medicine, St. Luke’s-Roosevelt Hospital Center, New York; Department of Medicine (C. Nonas), North General Hospital, New York; and Movement Disorders Clinic (Dr. Di Rocco, K. Boyar), Department of Neurology, Beth Israel Medical Center, New York.

Address correspondence and reprint requests to Dr. Theodore B. VanItallie, P.O. Box 775, Boca Grande, FL 33921-0775; e-mail: tedvani{at}ewol.com

Ketones may bypass the defect in complex I activity implicated in Parkinson disease (PD). Five of seven volunteers with PD were able to prepare a "hyperketogenic" diet at home and adhere to it for 28 days. Substituting unsaturated for saturated fats appeared to prevent cholesterol increases in four volunteers. Unified Parkinson’s Disease Rating Scale scores improved in all five during hyperketonemia, but a placebo effect was not ruled out.




This article has been cited by other articles:


Home page
 Annals of Clinical & Laboratory ScienceHome page
Z. G. Hu, H. D. Wang, W. Jin, and H. X. Yin
Ketogenic Diet Reduces Cytochrome c Release and Cellular Apoptosis Following Traumatic Brain Injury in Juvenile Rats
Ann. Clin. Lab. Sci., January 1, 2009; 39(1): 76 - 83.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. M. Freeman, E. H. Kossoff, and A. L. Hartman
The Ketogenic Diet: One Decade Later
Pediatrics, March 1, 2007; 119(3): 535 - 543.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. G. Jabre, B.-P. W. Bejjani, and T. B. VanItallie
Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study
Neurology, February 28, 2006; 66(4): 617 - 617.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study
Mazen G. Jabre, et al.
Neurology Online, 27 Jun 2005 [Full text]
Reply to Jabre et al
Ted VanItallie
Neurology Online, 27 Jun 2005 [Full text]